最小充分平衡随机化在序贯随机对照试验设计中的应用:ESCAPE试验结果
ESCAPE试验是一项前瞻性、多中心、随机临床试验,采用实时、动态、基于互联网的最小充分平衡随机化方法,对年龄、性别、基线NIHSS评分、动脉闭塞部位、基线ASPECTS评分及静脉阿替普酶治疗等基线协变量进行平衡。基于置换的组间差异检验证实性别(p=1.00)、基线NIHSS评分(p=0.95)、动脉闭塞部位(p=1.00)、基线ASPECTS评分(p=0.28)、静脉阿替普酶治疗(p=0.31)及年龄(p=0.67)等协变量组间平衡。结论认为该协变量自适应随机化方案在小样本试验和数据监测中具有可行性和获益。
要点
- ESCAPE试验采用最小充分平衡随机化,对年龄、性别、基线NIHSS评分、闭塞部位、基线ASPECTS评分及静脉阿替普酶治疗进行平衡。
- 置换检验证实性别(p=1.00)、基线NIHSS评分(p=0.95)、闭塞部位(p=1.00)、基线ASPECTS评分(p=0.28)、静脉阿替普酶治疗(p=0.31)及年龄(p=0.67)组间平衡。
- 该协变量自适应随机化方案在小样本试验和数据监测中具有可行性和获益。
核心结论
- ESCAPE试验结果表明,该协变量自适应随机化方案在小样本试验和数据监测中具有可行性和获益。
研究设计与样本
- ESCAPE试验为前瞻性、多中心、随机临床试验,纳入症状发作12小时内、年龄18岁及以上、基线NIHSS评分>5、ASPECTS评分>5、CTA显示颈动脉T/L或大脑中动脉M1段闭塞且CTA显示至少中等侧支循环的受试者。
- 患者采用实时、动态、基于互联网的最小充分平衡随机化方法进行随机化,平衡年龄、性别、基线NIHSS评分、动脉闭塞部位、基线ASPECTS评分及静脉阿替普酶治疗等基线协变量。
主要发现
- 基于置换的组间差异检验证实性别(p=1.00)、基线NIHSS评分(p=0.95)、动脉闭塞部位(p=1.00)、基线ASPECTS评分(p=0.28)、静脉阿替普酶治疗(p=0.31)及年龄(p=0.67)等基线协变量组间平衡。
关键数值与推荐
- 主要纳入标准:症状发作<12小时、年龄≥18岁、基线NIHSS评分>5、ASPECTS评分>5、CTA证据显示颈动脉T/L或大脑中动脉M1段闭塞、CTA显示至少中等侧支循环。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We describe the implementation of minimal sufficient balance randomization, a covariate-adaptive randomization technique, used for the "Endovascular treatment for Small Core and Anterior circulation Proximal occlusion with Emphasis on minimizing CT to recanalization times" (ESCAPE) trial. METHODS: The ESCAPE trial is a prospective, multicenter, randomized clinical trial that enrolled subjects with the following main inclusion criteria: less than 12 h from symptom onset, age 18 years or older, baseline NIHSS score > 5, ASPECTS score > 5 and computed tomography angiography (CTA) evidence of carotid T/L or M1-segment middle cerebral artery (MCA) occlusion, and at least moderate collaterals by CTA. Patients were randomized using a real-time, dynamic, Internet-based, minimal sufficient balance randomization method that balanced the study arms with respect to baseline covariates including age, sex, baseline NIHSS score, site of arterial occlusion, baseline ASPECTS score and treatment with intravenously administered alteplase. RESULTS: Permutation-based tests of group differences confirmed group balance across several baseline covariates including sex (p = 1.00), baseline NIHSS score (p = 0.95), site of arterial occlusion (p = 1.00), baseline ASPECTS score (p = 0.28), treatment with intravenously administered alteplase (p = 0.31), and age (p = 0.67). CONCLUSION: Results from the ESCAPE trial demonstrate the feasibility and the benefit of this covariate adaptive randomization scheme in small-sample trials and for data monitoring endeavors. TRIAL REGISTRATION: ESCAPE trial - NCT01778335 - at www.clinicaltrials.gov . Registered on 29 January 2013.
引用
- Sajobi TT, Singh G, Lowerison MW, et al. Minimal sufficient balance randomization for sequential randomized controlled trial designs: results from the ESCAPE trial. Trials. 2017. PMID: 29096678. doi:10.1186/s13063-017-2264-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。